EXTENDED RELEASE
FOR EXTENDED RELIEF
New ZILRETTA
NDC Number
65250-0003-01
HCPCS Code | HCPCS Code Descriptor | NDC Number | Labeler | NDC Description |
---|---|---|---|---|
J3304 | Injection triamcinolone acetonide, preservative free, extended release, microsphere formulation, 1 mg | New NDC: 65250-0003-01 | Pacira Biosciences | ZILRETTA (triamcinolone acetonide extended-release injectable suspension) single-dose kit. |
J3304 | Injection triamcinolone acetonide, preservative free, extended release, microsphere formulation, 1 mg | Existing NDC: 70801-0003-01 | Flexion Therapeutics | ZILRETTA (triamcinolone acetonide extended-release injectable suspension) single-dose kit. |
For more information, please contact reimbursement@pacira.com |
EXTENDED RELEASE
FOR EXTENDED RELIEF
Explore ZILRETTA and learn why it may be right for your patients experiencing OA knee pain.
LOCAL
RAPID
PERSISTENT
SAFETY
*Defined as time from IA injection to the first daily pain assessment of >30% improvement from baseline.
ZILRETTA is the only available extended-release intra-articular corticosteroid.
Get more information on ZILRETTA in your office or your inbox. Schedule a rep visit or sign up for email updates to be sure you have the latest information on new developments and support for you, your staff, and your patients.
REQUEST A REP/EMAIL SIGN-UPJohn Richmond, MD, reviews the clinical data for ZILRETTA and moderates a dynamic panel with Ira Evans, MD, Scott Sigman, MD, and Jason Rand, MD.
Watch The VideoWe’ve deployed the Z Team, a dedicated patient concierge program to connect patients with healthcare providers who have experience with ZILRETTA. Register to see if you are eligible to be part of our Provider Locator tool and let our Z Team members bring interested patients directly to you.
REGISTER YOUR OFFICE TODAYWe work within your established process and provide comprehensive access support at every step with FlexForward®
SEE HOW IT WORKSReferences:
X